RoadMap Tech Aims to Accelerate Healthcare Insights with Speedier Data Aggregation

By Patrick Walker

The relentless pursuit of better patient outcomes and more efficient healthcare delivery hinges on data – vast quantities of it. But accessing, cleaning, and securing that data remains a significant hurdle. RoadMap Technologies is aiming to address this bottleneck with the launch of its upgraded Data Aggregation System (DAS) 2.0, promising dramatically faster and more reliable access to de-identified patient data.

DAS 2.0 builds on RoadMap’s existing platform, offering enhanced capabilities in data ingestion, de-identification, and forecasting. The company claims a groundbreaking 37-minute average resolution time for IT support tickets—a figure they assert significantly outpaces the industry average—and boasts a median forecast accuracy within 2% of actuals. These claims, if substantiated, could represent a substantial step forward for healthcare analytics and predictive modeling.

Addressing a Critical Bottleneck

The sheer volume of healthcare data—electronic health records, claims data, genomic information, and data from wearable devices—is expanding exponentially. However, turning this data into actionable insights is often hampered by fragmentation, security concerns, and complex regulatory requirements. De-identification—the process of removing personally identifiable information—is crucial for protecting patient privacy while enabling data sharing for research and analytics.

“The ability to quickly and securely access de-identified data is paramount,” explains one industry consultant. “Many research projects are delayed or even stalled because of the time it takes to prepare data for analysis. A faster, more reliable platform could accelerate innovation and lead to more effective treatments.”

Beyond Speed: A Focus on Security and Compliance

RoadMap Technologies is betting that its commitment to security and compliance will differentiate it from competitors. The company has achieved HITRUST r2 Certified status – a rigorous certification that demonstrates a high level of security risk management. This certification is particularly important in the healthcare industry, where data breaches can have severe consequences.

“Achieving HITRUST r2 certification is a significant investment, but it’s essential for building trust with our clients,” says a RoadMap Technologies representative. “It demonstrates our commitment to protecting patient privacy and complying with industry regulations.”

Industry sources confirm that HITRUST certification is a significant differentiator. “The healthcare data landscape is crowded,” says one data scientist. “HITRUST certification sends a strong signal to potential clients that a company takes security seriously.”

Competition Heats Up in Data Aggregation Space

RoadMap Technologies is entering a competitive market with established players like Datavant, IQVIA, and Optum. These companies offer a range of data aggregation and analytics solutions, but RoadMap is positioning itself as a leader in speed and reliability.

While the precise competitive landscape varies depending on the specific capabilities offered, several companies are vying for market share. Datavant focuses on connecting and de-identifying health data, while IQVIA offers comprehensive analytics and research services. Optum leverages its vast access to healthcare data to provide insights and analytics.

“The market is becoming increasingly crowded,” says a data analyst specializing in healthcare. “Companies are vying for clients by offering unique features, such as faster processing times, more sophisticated analytics, or enhanced security.”

Forecasting Accuracy: A Key Differentiator?

RoadMap Technologies’ claim of a median forecast accuracy within 2% of actuals is particularly noteworthy. Accurate forecasting is crucial for a wide range of healthcare applications, including predicting patient demand, optimizing resource allocation, and identifying potential outbreaks.

“Forecasting accuracy is a major challenge in healthcare,” says a healthcare administrator. “Even small improvements in accuracy can have a significant impact on efficiency and patient care.”

However, independently verifying this claim is difficult without access to detailed data and benchmarks. The company says its proprietary algorithms and machine learning techniques enable it to generate highly accurate forecasts, but external validation is needed to confirm these claims.

Security Remains Paramount

Extensive research into potential security breaches involving RoadMap Technologies revealed no publicly available reports. This, combined with the company’s HITRUST r2 certification, suggests a robust security posture. Industry experts emphasize that maintaining data security is not merely a technical challenge but an ongoing process that requires constant vigilance.

“Security is not a one-time fix,” says a cybersecurity consultant specializing in healthcare. “It’s a continuous process that requires ongoing monitoring, assessment, and improvement.”

Looking Ahead

RoadMap Technologies’ DAS 2.0 represents a potential step forward in healthcare data aggregation and analytics. The company’s focus on speed, reliability, security, and forecasting accuracy could address critical challenges facing the industry. While independent verification of certain claims is needed, the company’s commitment to innovation and its focus on client needs position it for success in a rapidly evolving market. The key will be demonstrating tangible results and building trust with healthcare organizations that are increasingly reliant on data to drive better outcomes.